Mercury, identified thousands of years ago is one of the oldest toxicants known. The endocrine disruptive effects of mercury have recently become one of the major public concerns. In this report, the adverse effects of mercury on the hypothalamus, pituitary, thyroid, adrenal gland, and gonads (testis and ovary) in laboratory animals as well as in humans are reviewed. The effects of both environmental and occupational exposures to organic, inorganic, or metallic mercury are explained. There is sufficient evidence from animal studies supporting the disruptive effects of mercurials on the functions of the thyroid, adrenal, ovary, and testis, although several factors make it difficult to extrapolate the animal data to the human situation. However, the human studies performed so far, which focused mainly on serum hormone levels, failed to provide any conclusive data to confirm the findings from the animal studies. Therefore, further well-designed epidemiological studies are urgently needed. The possible mechanisms of the toxic effects are also discussed. The broad enzyme inhibition and the influence on the combining of hormones by their receptors, which seem due to its avid binding to sulphydryl, may account for the primary mechanism. The interference with intraceUular calcium metabolism, and peroxidation may also be involved.
Introduction
The endocrine system is one of the three important integrating and regulatory systems in the human body. The other two are the nervous and immune systems. The major endocrine glands include the hypothalamus, pituitary, thyroid, parathyroid, adrenal gland, pancreas, and gonads (ovary and testis). Hormones are natural secretory products of the endocrine glands and travel via the blood to exert their effects at distant target tissues or organs by binding to specific cell surfaces or nuclear receptors. They are responsible for the maintenance of homeostasis, reproduction, development, and behavior.
An endocrine disruptor is broadly defined as an exogenous agent, either synthetic or natural, that interferes with the synthesis, storage, release, transport, metabolism, binding, action, or elimination of natural hormones in the body. Investigators have expressed their concern over the estrogenic effects of environmental chemicals for nearly 30 years' 4~. In the 1990s, this concern has become intensified, and focused not only on environmental estrogens but also on any agents that pose adverse Received Aug. 30 1999/Accepted Nov. 13 1999 Reprint requests to: Xinqiang ZHU Department of Environmental Health, School of Medicine, Fukui Medical University, Matsuoka-cho, Fukui 910-1193, Japan. TEL: +81-776-618336 FAX: +81-776-618107 E-mail: Zhux@fmsrsa.fukui-med.ac.jp effects on any aspects of the entire endocrine system 5-,~. There have been hundreds of chemicals proved or suspected of having endocrine disruptive effects. They include natural products (i.e., phytoestrogens), pharmaceuticals (i.e., diethylstilbestrol, ethynyl estradiol), industrial chemicals (i.e., alkylphenols, bisphenol A), and environmental pollutants (i.e., DDT, PCBs, dioxin, and PAHs). It has been reported that the endocrine disruptors may have a variety of adverse biological effects on human health as well as on aquatic life or wildlife. They involve hormone dependent human cancers (breast, testicular and prostate cancers), abnormal sexual development, reduced male fertility, alteration in pituitary and thyroid functions, immune suppression, and neurobehavioral abnormalities. This evidence has drawn great attention from scientists, administrators as well as the public.
Among the numerous endocrine disruptors, the persistent environmental contaminants such as organochlorine pesticides, particularly DDT and its metabolites, polychlorinated biphenyls (PCBs), dioxins, and polyaromatic hydrocarbons have been given preferential concern and have been intensively investigated. More recently, increased attention has been focused on nonyl-phenol, bisphenol A, and phthalates for their wide usage. Heavy metals such as lead, cadmium, and mercury are also reported to have an endocrine disruptive potential. Therefore, they are also on the list of "known & suspected hormone disruptors" published by The 174
World Wildlife Fund">.
There have been several reviews on the endocrine disruptive effects of lead and cadmium but none on mercury. This review focuses on the reports of the adverse effects of mercury in which the common theme of endocrine disruption has been hypothesized, suspected or demonstrated. Available literature was searched for on Medline with the key word mercury combined with toxicity, hormone, endocrine, hypothalamus, pituitary, thyroid, adrenal, gonad, testis, and ovary, respectively. Other articles presented in the reference lists of those selected papers were also screened and, if they were useful, adopted. Both environmental and occupational exposure to organic or inorganic mercury was included. All the pathological, physiological or biochemical changes caused by mercury in all the endocrine organs are discussed if they were mentioned in the original papers. This report puts forward an overview of the current state of science relative to endocrine disruption in humans, wildlife, and laboratory animals, but is not intended to be an exhaustive review in general.
Mercury identified thousands of years ago is one of the oldest toxicants known. There are three main chemical forms of mercury: (1) organic mercury, used as fungicides, herbicides, and wood preservatives; (2) inorganic mercury, for antiseptic and dermatological preparations; and (3) elemental mercury, used in the production of batteries, thermometers, and fluorescent tubes. The exposure routes of mercury include the ingestion of food such as fish and seafood, dermal absorption, and inhalation. In addition, amalgam tooth fillings were identified as the major source of mercury contributing to the body burden in humans without occupational exposure '"~. It is well known that excessive exposure to mercury results in neurotoxic and nephrotoxic disorders. Moreover, mercury taken into the body is distributed and deposited in the endocrine glands as well as in the liver, kidney, brain, and other tissues of humans and laboratory animals ,, ,4). Thus, its latent effects on the endocrine system are also becoming a major concern. However, reports with the topic of endocrine disruptive effects of mercury are much fewer than those dealing with lead and cadmium. Therefore, we had to base our study on these relatively limited data for this review.
The effects on the hypothalamus
The hypothalamus and upper central nervous system are the top controllers and regulators of the hypothalamus-pituitarytarget gland (thyroid, adrenal gland, testis, and ovary) axis, and are simultaneously regulated by the lower glands as feedback.
Exposure to mercuric chloride, methylmercuric chloride, or mercury vapor resulted in mercury deposits in the hypothalamus of rats ,5. ,~,~. Methyl mercury was demethylated in the brain especially in the thalamus and pituitary where inorganic mercury increased to a higher extent and was eliminated considerably more slowly than in other brain sites m. Nevertheless, there are very few reports concerning the adverse effects of mercury on the hypothalamus in laboratory animals, and no reports concerning the human hypothalamus.
More than twenty years ago, Lamperti and Niewenhuis reported ultrastructural changes found in the neurons of the arcuate nucleus of female hamsters exposed to 1 mg of mercuric chloride daily during one estrous cycle. There was a significantly higher concentration of follicle stimulating hormone (FSH) and luteinizing hormone (LH) in the pituitaries of the mercury treated animals during certain periods of the estrous cycle.
However the plasma levels of FSH and LH were not interfered '>. A single injection of mercuric citrate resulted in a change in the circadian rhythm of the cytoplasmic RNA content and caused a general reduction of the RNA content in the hypothalamic neurons of mice '~>. It is well known that the hypothalamic hormones are released in a pulsatile manner, and isolated anterior pituitary target cells respond to pulsatile administration of these hormones better than to continuous exposure. Therefore, the alteration of the circadian rhythm of the cytoplasmic RNA content might imply an impairment of hypothalamic function. In addition, mercury was reported to inhibit the specific binding of luteinizing hormone-releasing hormone (LHRH) to the hypothalamic membrane 2o).
Up to the present, no epidemiological studies concerning human hypothalamic endocrine function have been reported.
The effects on pituitary
The anterior pituitary, under the control of hypothalamic hormones, secretes a number of hormones that regulate the growth and function of other endocrine glands. The posterior pituitary hormones regulate water balance and milk ejection from the lactating mammary gland.
Mercury was found to be deposited in the pituitaries of laboratory animals and humans after exposure to mercury by various routes ,3. 2,-25>. The amount of mercury deposits increased significantly in the pituitaries of adult rats exposed to methyl mercury at 20mg/l in drinking water 22>. Mercury was found to be present throughout the anterior pituitary. The lateral part of the gland contained significantly more mercury than the central part of the gland did. Intracellular accumulation of mercury was ultrastructurally localized in the lysosomes and granules of secretory cells, such as somatotrophs, thyrotrophs, and corticotrophs. While, apart from the vacuolation of lysosomes, no other structural damages were observed in the cells containing mercury 22>.
Nylander reported that mercury concentrations in the pituitary glands of three deceased dentists were significantly higher than those in the controls (135-349 Vs 5-97 ng/g wet weight) ,3>. However, there have not been any reports of definite pituitary dysfunction related to environmental or occupational exposure to mercury. Langworth et al reported that in a group of dental personnel exposed to mercury vapour, neither basal serum levels of thyroid-stimulating hormone (TSH), prolactin (PRL), thyroxine (T4), triiodothyronine (T3), and cortisol, nor the TSH and PRL responses to thyrotrophin-releasing hormone (TRH) were significantly different from those in the control group 27>. In the same year, Erfurth et al got the same result ~'~. They investigated a group of workers comprised 11 male workers with a mean exposure time of 4.5 years, a mean urinary mercury concentration of 26 nmol/mmol creatinine, and the blood mercury concentrations ranging from 70-170 nmol/l. Similarly, both the basal serum concentrations of pituitary hormones TSH, PRL, FSH, LH and their response after administration with thyrotrophin and gonadotrophin showed no difference between the exposed group and the control group~'~. These two epidemiological studies have the same limitation in results due to the small size of samples with only 11 exposed workers in each. Later on, McGregor and Mason carried out a study in a wellcharacterized population occupationally exposed to mercury vapour ~' >. Twenty-eight workers with urine mercury levels greater than 40 nmol/mmol creatinine were selected as an exposure 175
